NCT00210587View on ClinicalTrials.gov

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

December 31, 2005

Conditions
AnemiaNeoplasms
Interventions
DRUG

epoetin alfa

All Listed Sponsors
collaborator

Ortho Biotech Products, L.P.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210587 - An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation | Biotech Hunter | Biotech Hunter